Placental MRI Predicts Fetal Oxygenation and Growth Rates in Sheep and Human Pregnancy

Magnetic resonance imaging (MRI) assessment of fetal blood oxygen saturation (SO₂ ) can transform the clinical management of high-risk pregnancies affected by fetal growth restriction (FGR). Here, a novel MRI method assesses the feasibility of identifying normally grown and FGR fetuses in sheep and is then applied to humans. MRI scans are performed in pregnant ewes at 110 and 140 days (term = 150d) gestation and in pregnant women at 28⁺³  ± 2⁺⁵ weeks to measure feto-placental SO₂ . Birth weight is collected and, in sheep, fetal blood SO₂ is measured with a blood gas analyzer (BGA). Fetal arterial SO₂ measured by BGA predicts fetal birth weight in sheep and distinguishes between fetuses that are normally grown, small for gestational age, and FGR. MRI feto-placental SO₂ in late gestation is related to fetal blood SO₂ measured by BGA and body weight. In sheep, MRI feto-placental SO₂ in mid-gestation is related to fetal SO₂ later in gestation. MRI feto-placental SO₂ distinguishes between normally grown and FGR fetuses, as well as distinguishing FGR fetuses with and without normal Doppler in humans. Thus, a multi-compartment placental MRI model detects low placental SO₂ and distinguishes between small hypoxemic fetuses and normally grown fetuses.